Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomized, controlled trial
Christine Bodemer, Andrzej Kaszuba, Külli Kingo, Athanasios Tsianakas, Akimichi Morita, Enrique Rivas, P. Papanastasiou, Deborah Keefe, Manmath Patekar, Pascal Charef, L. Zhang, Susan Cafoncelli, C. Papavassilis
Journal of the European Academy of Dermatology and Venereology, 2020
Abstract
This research paper explore the methodology and findings associated with Journal of the European Academy of Dermatology and Venereology. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).